A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

NCT01172535 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

97

Enrollment

NIH

Sponsor class

Conditions

HIV

Interventions

DRUG: Lopinavir/ritonavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)